Literature DB >> 12742019

Structural basis for antibody catalysis of a cationic cyclization reaction.

Xueyong Zhu1, Andreas Heine, Frédéric Monnat, K N Houk, Kim D Janda, Ian A Wilson.   

Abstract

Antibody 4C6 efficiently catalyzes a cationic cyclization reaction. Crystal structures of the antibody 4C6 Fab in complex with benzoic acid and in complex with its eliciting hapten were determined to 1.30A and 2.45A resolution, respectively. These crystal structures, together with computational analysis, have elucidated a possible mechanism for the monocyclization reaction. The hapten complex revealed a combining site pocket with high shape complementarity to the hapten. This active site cleft is dominated by aromatic residues that shield the highly reactive carbocation intermediates from solvent and stabilize the carbocation intermediates through cation-pi interactions. Modeling of an acyclic olefinic sulfonate ester substrate and the transition state (TS) structures shows that the chair-like transition state is favored, and trapping by water directly produces trans-2-(dimethylphenylsilyl)-cyclohexanol, whereas the less favored boat-like transition state leads to cyclohexene. The only significant change observed upon hapten binding is a side-chain rotation of Trp(L89), which reorients to form the base of the combining site. Intriguingly, a benzoic acid molecule was sequestered in the combining site of the unliganded antibody. The 4C6 active site was compared to that observed in a previously reported tandem cyclization antibody 19A4 hapten complex. These cationic cyclization antibodies exhibit convergent structural features with terpenoid cyclases that appear to be important for catalysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742019     DOI: 10.1016/s0022-2836(03)00406-6

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  Crystal structures of a quorum-quenching antibody.

Authors:  Erik W Debler; Gunnar F Kaufmann; Robert N Kirchdoerfer; Jenny M Mee; Kim D Janda; Ian A Wilson
Journal:  J Mol Biol       Date:  2007-03-06       Impact factor: 5.469

2.  Structures of Abeta-related peptide--monoclonal antibody complexes.

Authors:  Anna Gardberg; Lezlee Dice; Kathleen Pridgen; Jan Ko; Paul Patterson; Susan Ou; Ronald Wetzel; Chris Dealwis
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

3.  Molecular basis for passive immunotherapy of Alzheimer's disease.

Authors:  Anna S Gardberg; Lezlee T Dice; Susan Ou; Rebecca L Rich; Elizabeth Helmbrecht; Jan Ko; Ronald Wetzel; David G Myszka; Paul H Patterson; Chris Dealwis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-25       Impact factor: 11.205

4.  Conformational isomerism can limit antibody catalysis.

Authors:  Erik W Debler; Roger Müller; Donald Hilvert; Ian A Wilson
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

5.  Probing the antibody-catalyzed water-oxidation pathway at atomic resolution.

Authors:  Xueyong Zhu; Paul Wentworth; Anita D Wentworth; Albert Eschenmoser; Richard A Lerner; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.